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The natural killer (NK) cell activating receptor NKp46/NCR1 plays a critical role in 
elimination of virus-infected and tumor cells. The NCR1 gene can be transcribed into five 
different splice variants, but the functional importance and physiological distribution of 
NKp46 isoforms are not yet fully understood. Here, we shed light on differential expression 
of NKp46 splice variants in viral respiratory tract infections and their functional difference 
at the cellular level. NKp46 was the most predominantly expressed natural cytotoxicity 
receptor in the nasal lavage of patients infected with four respiratory viruses: respiratory 
syncytia virus, adenovirus, human metapneumovirus, or influenza A. Expression of 
NKp30 was far lower and NKp44 was absent in all patients. Domain 1-negative NKp46 
splice variants (i.e., NKp46 isoform d) were the predominantly expressed isoform in nasal 
lavage following viral infections. Using our unique anti-NKp46 mAb, D2-9A5, which 
recognizes the D2 extracellular domain, and a commercial anti-NKp46 mAb, 9E2, which 
recognizes D1 domain, allowed us to identify a small subset of NKp46 D1-negative 
splice variant-expressing cells within cultured human primary NK cells. This NKp46 
D1-negative subset  also showed higher degranulation efficiency in term of CD107a 
surface expression. NK-92 cell lines expressing NKp46 D1-negative and NKp46 
D1-positive splice variants also showed functional differences when interacting with 
targets. A NKp46 D1-negative isoform-expressing NK-92 cell line showed enhanced 
degranulation activity. To our knowledge, we provide the first evidence showing the 
physiological distribution and functional importance of human NKp46 splice variants 
under pathological conditions.
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inTrODUcTiOn
Acute viral respiratory tract infections represent a major public 
health and economic problem, affecting all age groups and caus-
ing severe disease, especially in infancy and old age. Various 
respiratory viruses, such as respiratory syncytial virus (RSV), 
influenza viruses, parainfluenza viruses, and adenoviruses may 
cause respiratory illness. In particular, RSV is the leading cause 
of hospitalization for respiratory tract illnesses in young children 
(1). Cellular immune responses play a major role in viral clear-
ance. However, they can play a pivotal role in contributing to the 
pathogenesis of chronic diseases, e.g., asthma and apnea, in some 
cases (2, 3). The reported clinical manifestations for viral res-
piratory infections are largely overlapping, suggesting common 
regulatory pathways. Despite extensive diagnostic investigations 
of the operative cellular immune responses to respiratory infec-
tions, the role of natural killer (NK) cells and their involvement 
in immune responses to acute upper and lower respiratory tract 
infections remain largely unknown (4). NK cells have been found 
to be the major (25%) immune cells in non-squamous nasal lav-
age (5), but the specific type of NK-cells or their activity were not 
studied.
Natural killer cell activity is regulated by a balance between 
signals delivered by inhibitory and activating receptors. The 
natural cytotoxicity receptors (NCRs) NKp46 (NCR1), NKp44 
(NCR2), and NKp30 (NCR3), as well as NKG2D, are the main 
activating receptors involved in mediating NK cell function in 
health and disease (6, 7). NCR and NKG2D mRNAs are subjected 
to alternative mRNA splicing events, resulting in the generation 
of splice variants that could mediate different and even opposing 
functions for the same receptor. For NKp30, three splice variants 
were reported: NKp30a, NKp30b, and NKp30c. NKp30a and 
NKp30b are considered as immune stimulatory isoforms and 
lead to increased IFN-γ and TNF-α secretion, while NKp30c 
leads to IL-10 secretion and immunosuppression. NKp30 splice 
variants have been studied by us and others in cancer, viral 
infection, and pregnancy (8–13). Also, three splice variants for 
NKp44 were reported: NKp44-1, NKp44-2, and NKp44-3. We 
were the first to report that the ITIM-positive NKp44-1 splice 
variant could serve as an inhibitory receptor when co-incubated 
with target cells expressing PCNA (14), and our findings with 
regard to the NKp44-PCNA inhibitory axis were corroborated 
by others (15). In acute myeloid leukemia (AML), sole expres-
sion of NKp44-1 was associated with poor survival of newly 
diagnosed patients (14). A NKp44-1-dominant inhibitory 
profile predominated in healthy pregnancy gestation, but pre-
ponderance of a NKp44 activation phenotype, was associated 
with pregnancy disorder (10). For NKG2D, it was reported that 
a truncated human NKG2D splice isoform negatively regulates 
NKG2D-mediated function (16).
Interestingly, no studies of the function and distribution of 
NKp46 splice variants have been published to date. Here, we 
studied the expression of NCRs in nasal lavage following res-
piratory viral infection and observed that NKp46 was expressed 
abundantly. The NKp46 receptor has five main splice variants 
divided into a group that contains both extracellular domains 
(3 isoforms) and a group that does not express the D1 domain 
(2 isoforms) (11, 17). Interestingly, the D1-negative NKp46 
splice variants were the predominant isoforms expressed in 
nasal lavage following viral infection. We further showed that 
the D1-negative NKp46 splice variants are more active in both a 
NK cell line and primary human NK cells.
MaTerials anD MeThODs
antibodies and Fusion-ig Proteins
The following fluorochrome conjugated anti-human mono-
clonal antibodies were used for flow cytometry: anti-CD3 (PE, 
IQproducts), anti-CD56 (allophycocyanin, BioLegend), anti-
CD16 (Pacific blue, BioLegend), anti-NKp46 (Alexa Fluor 647, 
clone 9E2, BioLegend), anti-NKp46 (iFluro 488, clone D2-9A5, 
Gen-Script), and anti-CD107a (BrilliantViolet 421, BioLegend). 
Purified anti-human monoclonal antibodies used for cell 
stimulation were anti-NKp30 (clone 210847, R&D Systems) and 
anti-NKp46 (clone D2-9A5). Monoclonal antibody D2-9A5 was 
generated using hybridoma technology described previously (18). 
HRP-conjugated goat anti-mouse IgG, Fcγ fragment-specific 
(Jackson ImmunoResearch Laboratories) antibody was used as 
secondary antibody. Recombinant NKp46 receptor Ig proteins, 
respectively, NKp46-D1 Ig, NKp46-D2 Ig, NKp46-Full Ig, and 
Human Fc were generated as described previously (19, 20).
generation of nKp46 Domain 1+ and 
nKp46 Domain 1− isoform-expressing nK 
cell lines and cell culture
NKp46 full length, i.e., domain 1+ (isoform a; matching 
NM_004829.5) and NKp46-D2, i.e., domain 1− (isoform d; match-
ing NM_001242356.1) cDNA were N-terminal FLAG-tagged 
and cloned into pBMN-IRES-GFP retroviral vector. NK-92 cells 
(ATCC CRL-2407), derived from human NK cell leukemia were 
then transduced with the constructs to produce NK-92-NKp46-
Full (NK92-46Full) and NK-92-NKp46-D2 (NK92-46D2) cell 
lines, respectively. Retroviral transduction was performed as pre-
viously described (21–24). NK-92 cell lines were then grown in 
Alpha-MEM medium (Gibco, Life Technologies) supplemented 
with 10% horse serum, 10% FBS, 0.2 mM myo-inositol (Sigma), 
0.1 mM β-mercaptoethanol (Sigma), 0.02 mM folic acid (Fisher 
Scientific), 100 IU/mL of recombinant human IL-2 (PeproTech), 
and 1% penicillin/streptomycin (Life Technologies). HEK293T, 
SV40 large T Ag-transfected HEK293 cells (CRL-11268) were 
used as target cell lines. HEK293T cells were cultured in DMEM 
(Gibco, Life Technologies) medium supplemented with 10% FBS 
and 1% penicillin/streptomycin. Cell lines were grown in a 5% 
CO2 humidified 37°C incubator.
isolation and culture of Primary human 
nK cells
Natural killer cell isolation was done from peripheral blood 
of healthy volunteer donors, who were recruited by informed 
consent as approved by the Ben-Gurion University of The Negev 
Institutional Review Board, using the RosetteSep Human NK cell 
Enrichment Cocktail kit (Stem Cell Technologies). After purifica-
tion, cells were cultured in CellGro stem cell serum-free growth 
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medium (CellGenix) supplemented with 10% heat-inactivated 
human plasma from healthy donors, 1  mM sodium pyruvate, 
2  mM l-glutamine, 1× MEM non-essential amino acids, 1% 
penicillin/streptomycin, 10 mM HEPES (Life Technologies), and 
300 IU/ml human IL-2 (PeproTech) (23, 25).
samples
Respiratory specimens, mainly nasal washes, were routinely 
obtained from hospitalized children with acute respiratory tract 
infection or from healthy children undergoing elective procedures 
(control group). Samples of nasopharyngeal washing (NPW) 
were tested for respiratory virus infections by real-time PCR (26). 
Briefly, nucleic acid extraction was performed using NucliSense 
EasyMag (Biomerieux, Marcy l’Etoile, France), according to 
the manufacturer’s instructions. One milliliter of aspirate was 
extracted into 50 µl of elution solution. Amplification was carried 
out in a final volume of 10 µl, using the RNA Ultrasense One-step 
qRT-PCR system (Invitrogen, Carlsbad, CA, USA) with 4 µl of 
nucleic acid and four sets of primers and probes to detect four 
viruses, and an internal control (IC) set (27). Samples positive 
for respiratory syncytia virus (RSV), adenovirus (ADV), human 
metapneumovirus (HMPV), or influenza A (FLUA H1N1 strain), 
along with healthy controls, were included in the study.
Ethics Statement
The number of the Ethics Committee approval is 0113-14-SOR. 
The approval is to get respiratory specimens from children under 
5  years old (hospitalized or healthy controls undergoing elec-
tive procedures). It includes the requirement to sign a written 
informed consent by the parents.
rna extraction, reverse Transcription, 
real-time reverse Transcriptase 
Polymerase chain reaction (qrTPcr), 
and Primer set efficiencies
qRTPCR for NCRs
The sets of primers and probes used to detect the NCRs were 
all designed to span an intron or a splice junction, and thus test 
differentially spliced RNA transcripts, avoiding testing of DNA in 
the samples. The primers and probes were described in Table S1 
in Supplementary Material. Each sample (extracted as described 
above, from NPW) was tested in parallel for NKp30, NKp44, 
and NKp46. Amplification was carried out in a final volume of 
20  µl, using the RNA UltraSense One-Step qRT-PCR system 
(Invitrogen, Carlsbad, CA, USA) with 4 µl of nucleic acid and the 
relevant set of primers and probes. Samples that were positive for 
NKp46 were further analyzed for the NKp46 isoforms, specifi-
cally the presence of D1 domain, see Table S2 in Supplementary 
Material for primers–probes combinations.
Flow cytometry
Human primary NK cells (105 cells/condition) were incubated 
with CD3-PE, CD56-APC, and CD16-Pacific blue mAbs (1 µg/
ml) on ice for 1 h, washed and NK purity was checked. Primary 
NK cells from day 14, 21, and 28 culture were double stained 
on ice with anti-NKp46-Alexa Fluor 647 (clone 9E2) and 
anti-NKp46-iFluro 488 (clone D2-9A5) mAbs (1 µg/ml) for 1 h, 
washed and assessed for isoform development. Flow cytometry 
was done using on a Gallios instrument (Beckman Coulter) and 
FACS data were analyzed using FlowJo software (Tree Star, Inc.).
cell stimulation and Flow cytometry-
Based Degranulation assay
For the NK cell degranulation assay, 96 well U-bottom plates 
were coated with 1.5 and 5  µg/ml of anti-NKp46 mAb (clone 
D2-9A5) and anti-NKp30 (clone 210847) mAb overnight at 4°C. 
After washing, 105 human primary NK cells were added for each 
condition along with BrilliantViolet 421-conjugated anti-CD107a 
mAb (1:400 final dilutions). After 4 h of incubation (37°C, 5% 
CO2), cells were washed and stained again with the same anti-
CD107a mAb (1:400 final dilution) and anti-NKp46 conjugated 
with Alexa Fluor 647 (clone 9E2). Percentages of CD107a+ cells 
were assessed from both 9E2-positive and -negative population. 
The NK-92 cell line was transduced to express NKp46 full-IRES-
GFP (NK92-46Full) and the NK-92 cell line expressing NKp46 
D2-IRES-GFP (NK92-46D2) were separately co-incubated for 
4 h (37°C, 5% CO2) with HEK293T cells using a E:T ratio of 1:1, 
1:2, or 1:5 along with BrilliantViolet 421-conjugated anti-CD107a 
mAb (1:400 final dilutions). Then, the cells were washed and 
stained again with BrilliantViolet 421-conjugated anti-CD107a 
mAb (1:400 final dilutions). NK-92 cells expressing the same 
level of GFP (correlating with equivalent levels of NKp46 isoform 
expression) were gated and percentages of CD107a+ cells were 
analyzed. Flow cytometry was done using Gallios instrument 
(Beckman Coulter) and FACS data were analyzed using FlowJo 
software (Tree Star, Inc.).
elisa assay
ELISA plates were coated overnight at 4°C with 1 µg/ml of recom-
binant NKp46 receptor Ig proteins (NKp46-D1 Ig, NKp46-D2 Ig, 
and NKp46-Full Ig) and Human Fc as control. After washing, the 
plates were blocked with skimmed milk followed by incubation 
with 1 µg/ml of anti-NKp46 mAb (clone 9E2 or clone D2-9A5). 
Detection was done using HRP-conjugated goat anti-mouse IgG 
(1:1000 final dilution). OD was measured at 650 nm with a Dynex 
Technologies MRX microplate reader.
statistical analysis
Graphics and statistical analysis were performed using GraphPad/
Prism5, OriginPro8, and Microsoft Office/Excel software. 
Statistical significance was calculated using Mann–Whitney U 
or Wilcoxon rank-sum test and One-way ANOVA. p < 0.05 was 
considered statistically significant.
resUlTs
expression of ncrs, nKp46 isoforms, and 
cytokines in nasal lavage
The assessment of NCR expression in the upper airways during 
viral infection was carried out using qRTPCR analysis. Three 
sets of primers and probe (Tables S1 and S2 in Supplementary 
Material) were designed for each of the three NCRs (NKp46, 
FigUre 1 | Viral respiratory infections are accompanied by a specific 
pattern of natural cytotoxicity receptor (ncr) expression. Nucleic 
acids were extracted from nasal wash samples, obtained from patients with 
respiratory viral infections, respectively, respiratory syncytial virus, adenovirus, 
human metapneumovirus, and influenza A, along with healthy controls and 
then were tested for mRNA expression of the three NCRs (NKp30, NKp44, 
and NKp46) by qRTPCR. (a) Depicted are the number of patients positive 
and negative for expression of NKp46, as well as NKp30. Purified PBMCs 
from healthy controls or whole blood served as a positive control in each test. 
NKp44 receptor expression was not found in any of the samples. (B) NKp46 
mRNA expression was compared between healthy and each of the 
virus-infected groups. Graph bars show mean ± SEM. Statistical significance 
was calculated by Mann–Whitney U or Wilcoxon rank-sum test. p < 0.05 
was considered as statically significant.
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NKp44 and NKp30). Samples taken from nasal lavage (using nasal 
wash) of hospitalized patients with respiratory tract infection 
were tested. The most prevalent viruses that are found in these 
patients were chosen: 34 infected with RSV (respiratory syncy-
tial virus) and 12 infected with HMPV, both ssRNA(+) viruses 
from the Pneumoviridae family; 24 infected with ADV, dsDNA 
viruses; and 14 infected with FLUA (influenza A) a segmented 
ssRNA(−) virus from the Orthomyxoviridae. Fifteen samples of 
healthy controls that arrived to the hospital for elective surgery 
were included in the study as well. Expression of the three NCRs 
was tested along with an IC, which is used to monitor for RNA 
extraction and for the PCR process (ERV-3 transcript, see Table 
S1 in Supplementary Material). To summarize, 83% (70 out of 84) 
of the infected samples were positive for NKp46 receptor, 18% 
(15 out of 84) were positive for NKp30, and none were positive 
for NKp44 (Figure  1A, detailing for the different viruses). All 
NKp30-positive samples were also positive for NKp46.
In the healthy control samples, 27% (4 out of 15) were 
positive for NKp46 and none was positive for NKp30 or NKp44 
(Figure 1A). However, NKp46 expression in the nasal lavage of 
the infected samples was considerably higher as compared to 
the NKp46 expression in the nasal lavage of the four NKp46+ 
healthy controls (Figure 1B). The fact that NKp46 was widely 
detected in samples from infected individuals (88, 79, 71, and 
92% for RSV, ADV, FLUA, and HMPV, respectively, Figure 1A), 
but not in most healthy individuals, suggests that NKp46 is a 
preferred receptor in the immune cells infiltrating the nasal 
lavage during viral infections regardless of the type of viral 
infection.
Natural killer cells, the prototypical member of group 1 innate 
lymphoid cells (ILCs) express NKp46 (28, 29) and can invade 
nasal lavage (30, 31).
We, next, investigated the expression of NKp46 isoforms in 
the nasal lavage following respiratory viral infection. Differential 
expression of NKp30 and NKp44 isoforms was reported for 
different diseases (8–10, 12–14, 16); yet, the distribution of 
NKp46 isoforms was not studied. The NKp46 receptor has five 
main splice variants divided into two groups; one group (3 splice 
variants) contains the domain 1 (D1) region (contains Exon 3) 
and the other group (2) does not contain the D1 region (lacks 
Exon 3) (17). We previously published that domain 2 (D2) but 
not domain 1 (D1), of NKp46 is involved in the recognition of 
cellular ligands and that recognition of viral hemagglutinins 
(HA) involve the hinge region connecting domain 2 to the NK 
cell membrane (32). Therefore, we assessed the expression of 
D1-positive NKp46 mRNAs in nasal lavage following respiratory 
viral infection. The samples were screened by qRTPCR, and the 
results are shown in Figure  2. In parallel, each assay included 
three positive controls: NK cell lines (positive control cell line that 
contains D1-negative and D1-positive NKp46 isoforms), isolated 
PBMCs, and whole blood samples of healthy adult individuals 
(the latter two are depicted in Figure 2). Figure 2 shows that most 
of the samples from the nasal lavage expressed NKp46 that lacked 
the D1 domain (75, 71, 57, and 77% for RSV, ADV, FLUA, and 
HMPV, respectively). In contrast, none of the positive controls 
was negative for expression of the NKp46 D1 isoforms (Figure 2 
for PBMC/blood controls).
nK-92 cell line expressing the nKp46-
isoform d (D1-negative) is Functionally 
More active Than nK-92 cell line 
expressing the canonical nKp46-isoform 
a (D1-Positive)
The NKp46 receptor consists of two Ig-C2-like ectodomains, 
D1 and D2 (33). As aforementioned, the NKp46 receptor has 
five main splice variants divided into a group that contains both 
FigUre 2 | expression of D1-positive nKp46 isoforms in nasal wash is rare. The presence or absence of NKp46 D1-positive isoforms in samples were 
tested using two sets of specific primers and probes that span exon4 and exon5 (for NKp46 total) and the D1-positive region (Exon3, see Tables S1 and S2 in 
Supplementary Material for details). Shown are the total number of NKp46 receptor-positive samples that were found in each type of virus tested, and distribution of 
D1-positive isoforms and D1-negative isoforms (calculated from the subtraction of D1-positive samples from the number of samples positive for total NKp46). 
Purified PBMCs from healthy controls or whole blood served as a positive control in each test. *Low levels of D1-negative splice variants were shown for PBMCs in 
a different qRTPCR assay with a Fw-primer targeting the conjugated Ex2–Ex4 sequence (following the exclusion of the Domain-1 coding Exon 3). However, in this 
Figure, D1-negative is calculated as described above.
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ectodomains (3 isoforms) and a group that does not express the 
D1 domain (2 isoforms) (11, 17). We, thus, investigated the func-
tion of a representative from each group: the canonical NKp46 
receptor, i.e., NKp46 full (isoform a; matching NM_004829.5) 
and the single domain NKp46-D2 (isoform d; matching 
NM_001242356.1) (Figure 3A).
We generated NK-92 cell lines expressing splice variants a 
(D1-positive) and d (D1-negative) using a lentiviral gene delivery 
approach (NK92-46Full and NK92-46D2, respectively) and stud-
ied degranulation activity of these two cell lines upon interaction 
with cancer cells. We measured the CD107a surface expression 
as a degranulation marker. NK92-46Full and NK92-46D2 were 
co-incubated with HEK293T cell line in an E:T ratio of 1:1, 1:2, 
1:5 for 4 h and CD107a surface staining was performed. Since 
GFP was co-expressed with the transduced NKp46 splice vari-
ant, we could measure CD107a expression for NK92-46Full and 
NK92-46D2 expressing the same levels of transduced NKp46. 
We observed that for each E:T ratio, degranulation efficacy was 
significantly higher for NK92-46D2 as compared to NK92-46Full 
cells (Figure 3B, summary of 3 experiments).
cultured human Primary nK cells Develop 
a nKp46 D1-negative-Dominant 
subpopulation Manifesting higher activity
We previously developed the anti-NKp46 mAb, D2-9A5, which 
recognizes NKp46D2 (34). An ELISA assay to test for reactivity 
of the commercial anti-NKp46 mAb, clone 9E2, with recombi-
nant NKp46D1-Ig, NKp46D2-Ig, and NKp46full-Ig revealed 
the recognition of NKp46D1 and NKp46full, but not NKp46D2 
(Figure S1 in Supplementary Material). In contrast, D2-9A5 mAb 
recognized NKp46D2 and NKp46full, but not NKp46D1 (Figure 
S1 in Supplementary Material). Neither mAb reacted with nega-
tive control human Fc (Figure S1 in Supplementary Material). 
Similarly, the 9E2 mAb stained very positively NK92-46Full 
cells but to a significantly lesser extent the NK92-46D2 cells, 
while D2-9A5 mAb stained both cell lines similarly (Figure S2 
in Supplementary Material). The low staining of NK92-46D2 by 
9E2 antibody probably reflects the endogenous NKp46 expressed 
by NK-92 cells. Since both mAbs stain different domains, cross-
reactivity is not a likely scenario. Yet, we did test for cross-reactivity 
by staining purified primary human NK cells either with each of 
the mAbs alone or by double staining with both mAbs. Figure 
S3 in Supplementary Material shows that the intensity of single 
staining with each of the mAbs was similar to its staining intensity 
in the double staining condition; thus demonstrating that 9E2 
does not block D2-9A5 and vice versa. Therefore, we could use 
these antibodies together in flow cytometry analysis to test for the 
presence of a primary human NK subset in healthy controls that 
expresses only/mostly the D1-negative splice variant, as predicted 
from the RTPCR results from the nasal lavage of patients infected 
with respiratory viruses (Figure 2).
Since we could not retrieve live NK cells from nasal lavage 
of infected patients, we tested PBMCs. In freshly purified NK 
FigUre 3 | natural killer (nK)-92 cell line expressing the nKp46 
D1-negative isoform is functionally more active than nK-92 cell line 
expressing the canonical nKp46. (a) Schematic diagram of the canonical 
NKp46 receptor, i.e., NKp46 full (isoform a; matching NM_004829.5) and 
D1-negative splice variants of NKp46 receptor, i.e., NKp46 D2 (isoform d; 
matching NM_001242356.1). Domain 1(D1) within exon3, domain 2(D2) 
within exon4, transmembrane domain, and cytoplasmic domain (CY) within 
exon7 are marked. “A” shown between exons 5 and 6 note the Alanine AA 
existing in these isoforms. (B) To show degranulation efficiency, NK-92 cell 
line expressing NKp46 full, IRES-GFP (NK92-46Full), and NK-92 cell line 
expressing NKp46 D2, IRES-GFP (NK92-46D2) were co-incubated for 4 h 
with HEK293T cells then washed and stained for CD107a. Percentages of 
CD107a positive cells were analyzed by flow cytometry. The results are from 
three experiments. Graph bars show mean ± SEM. p < 0.05, ANOVA.
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cells, we could not observe a subset that expresses only the 
NKp46D1-negative splice variants. Yet, when we cultured 
human primary NK cells in the presence of 300 IU of recom-
binant human IL-2, they gradually developed a small but very 
distinct subpopulation that express only NKp46D1-negative 
splice variants, i.e., cells that were stained with D2-9A5 mAb, 
but not with 9E2 mAb. The D2-9A5+9E2− NK subset was 
evident at levels of 5% (14-day culture), 8% (21-day culture), 
and 10% (28-day culture) (Figures  4A,B). To investigate the 
functional relevance of this subset in primary NK cells, we 
assessed the degranulation potential of these cells as compared 
to the D2-9A5+9E2+ cultured NK cells. We stimulated the cells 
with anti-NKp30 or with anti-NKp46 (D2-9A5) mAbs and 
tested CD107a expression. Figure 4C shows that cultured NK 
cells lacking the D1 domain (D2-9A5+9E2-) were significantly 
more active as compared to cultured NK cells expressing the 
D1 domain (D2-9A5+9E2+). Taken together, our data reveal 
the evolution of NKp46 splice variants within primary NK 
cells over time, and their differential ability to release cytolytic 
granules.
DiscUssiOn
We showed that NKp46 is not expressed regularly in the nasal 
lavage of healthy controls, but this receptor was highly expressed 
in the human nasal lavage from patients infected with various 
respiratory viruses (Figure 1). NKp46 is constitutively expressed 
by NK cells that are part of group 1 ILCs (28, 29). Other ILCs, 
such as intraepithelial (lung and intestine) ILC1 and NCR+ ILC3 
subsets, also expressed NKp46 (28). Most non-NK ILC subsets 
that constitutively express NKp46, also manifest constitutive 
expression of NKp44; in contrast, peripheral blood NK cells 
express NKp44 only after stimulation. Therefore, our failure to 
observe any NKp44 expression in the human nasal lavage in 
parallel with NKp46 expression, indicates that the ILCs migrating 
to the nasal lavage upon respiratory nasal infection, are probably 
NK cells (35, 36).
Natural killer cells are capable of migrating to virus-infected 
tissue (30, 31) and specifically for IV infection, CCR2 was shown 
in mice to mediate the migration of NK cells during influenza 
virus infection (37). The immunopathology of upper respira-
tory tract viral infection is characterized by a complex interplay 
between respiratory virus, resident lung epithelial cells and infil-
trating innate and adaptive immune cells. NK cells are one of the 
important immune cell types recruited into the infected respira-
tory tract to clear virus and resolve the infection. In addition to 
directly killing virus-infected cells, NK cells produce significant 
amounts of IFN-γ to augment cytotoxic T lymphocyte activity 
(31). NKp46 is a primary activating receptor mediating NK cell 
antiviral function (6, 7); a number of virus-derived ligands rec-
ognized directly by NKp46 have been reported. We have shown 
that NCRs, particularly NKp46, are involved in the functional 
recognition of viral HA and hemagglutinin-neuraminidases 
(38–41). Other groups have similarly reported the involvement 
of NKp46 and other NCRs in the recognition of viruses (42, 43).
The NKp46 receptor can be encoded by five major splice 
variants that can be divided into a group that contains both ecto-
domains (3 isoforms) and a group that does not express the D1 
domain (2 isoforms) (11, 17). We showed that D1-positive splice 
variants are rare in the nasal lavage; therefore, the D1-negative 
splice variants are the dominant splice variants in the nasal lav-
age following respiratory viral infection (Figure 2). These results 
are in concordance with our previous reports that the NKp46 
recognition site of viral ligands involve the membrane-proximal 
domain (domain 2) and the hinge peptide connecting NKp46-D2 
to the cell membrane, but does not involve the membrane distal 
domain D1 (32). Differential tissue distribution of NCR splice 
variants has been previously reported for NKp30 and NKp44, but 
this is the first report of differential distribution of NKp46 splice 
variants. It was previously reported that NKp30 and NKp44 splice 
variant profiles differ between decidua basalis NK (dNK) cells 
and peripheral blood NK (pNK) cells. The NKp44-1 splice variant 
was shown to be significantly expressed in dNK cells compared to 
pNK cells, and the decidual cytokine milieu can change the splice 
variant profile of pNK cells to mimic that of dNK cells (11). Our 
recent observations also showed that a NKp44-1dominant inhibitory 
profile predominates in dNK cells in healthy pregnancy gestation, 
whereas a NKp44-2/3dominant activation profile proved to be more 
FigUre 4 | continued
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FigUre 4 | continued 
human primary natural killer (nK) cells when cultured in vitro became enriched with a distinct subpopulation expressing mostly the nKp46 
D1-negative isoforms (nKp46 D2) that are functionally more active. (a) Primary NK cells were stained with anti-CD3, anti-CD56, and anti-CD16 mAb to 
determine the percentage of CD3- CD56+ NK cells and their CD16 expression. (B) Primary NK cells were double stained with anti-NKp46-Alexa Fluor 647 (clone 
9E2) and anti-NKp46-iFluor 488 (clone D29A5) mAb at day 14, 21, and 28 of culture to show the development of NKp46 D1-negative isoforms. (c) When primary 
NK cells of day 28 culture were cross-linked for 4 h in a 96-well plate, coated with anti-NKp46 mAb (clone D29A5) and anti-NKp30 (clone 210847), then double 
stained with anti-CD107a and anti-NKp46 (clone 9E2), NK cells expressing the NKp46 D1-negative isoform became more active. Staining results were analyzed by 
flow cytometry. The results are from one representative experiment of triplicates. Graph bars show mean ± SEM (p < 0.05, ANOVA.
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prevalent in cases of spontaneous abortions. No significant differ-
ences were observed in NKp30 splice variant expression profiles 
in dNK cells when comparing healthy gestation and spontaneous 
abortions (44). Recently we also reported that among the three 
different splice variants of NKp44, the inhibitory NKp44-1 
isoform was significantly associated with poor survival of AML 
patients (14). In the case of gastrointestinal sarcoma tumors 
(GIST), distinct NKp30 splice variant profiles were observed in 
peripheral blood NK cells, as compared to healthy individuals 
(8). In that study, the immunosuppressive NKp30c isoform was 
expressed more prominently in individuals with GIST (8).
The differential distribution of NKp30 and NKp44 splice 
variants was associated with alterations in function of the dif-
ferent splice variants. In particular, inhibitory splice variants 
were identified and characterized for both NKp30 and NKp44 
(8, 14, 44). In our studies with NK cell lines transfected with dif-
ferent NKp46 splice variants, we showed a functional difference 
between a D1-positive and a D1-negative splice variant, with a 
tendency of the D1-negative splice variant to exert a better NK 
cell degranulation response (Figure 3). Yet, this difference could 
not define the D1-positive splice variant as a suppressor variant. 
We were able to use anti-NKp46 mAbs that specifically stain 
domain 1 or domain 2, to identify primary human NK cells that 
more readily express D1-negative splice variants (Figures S1–S3 
in Supplementary Material). NK cells expressing only the NKp46 
D1-negative splice variants were negligible in peripheral blood; 
yet, following prolonged in vitro culture with IL-2, a small but 
distinct NK subset expressing mostly the D1-negative splice vari-
ants was observed. In accordance with the results from the NK 
cell lines, these D1-negative primary human NK cells exhibited 
a significantly better degranulation response, as compared to 
the other IL-2 cultured NK cells expressing both D1-negative 
and D1-positive NKp46 transcripts (Figure  4). We previously 
reported the evolution of a NK cell subset expressing a specific 
splice variant of NKp44 (14, 44), and the microenvironment of 
placenta, as well as tumor, was enriched with TGF-β and other 
cytokines that can actively modulate NKp44 splice variant 
expression. The development of NK cells expressing inhibitory 
NKp44 and NKp30 splice variants, orchestrated by cytokine 
milieu within placenta and tumor, provides a unique mechanism 
of immune tolerance.
The question whether or not the two splice variant groups 
(D1-negative and D1-positive NKp46 isoforms) are mutually 
exclusive, or can exist within the same NK cell, remained to 
be further explored. Yet, our D1–D2 antibody staining results 
of IL-2-maintained primary NK cells indicate the develop-
ment of NK cell subset expressing mostly the D1-negative 
splice variants. Single-cell genomic analysis assays should be 
performed to assess the RNA splice variant distribution in the 
level of the single cell. Following the setting of single NK cell 
expressing mostly the D1-negative splice variants, the second 
subject to be resolved is whether the NK cells migrating to an 
active site are comprised mostly from cells expressing the same 
pattern of splice variants. Our results with the nasal lavage 
 following respiratory viral infection point to a setting of NK cells 
manifesting similar phenotype of NKp46 D1-negative splice 
variants. Our recent studies with NKp44 splice variants indicate 
that dominant expression of splice variant (NKp44 isoform 1) 
can be observed in NK clones (14); moreover, we showed that 
NK cell subset in specific organs, e.g. the first trimester decidua 
in normal pregnancy, has the same splice variant profile which 
is mostly NKp44 isoform 1 (44).
To recapitulate, for the first time, this study demonstrates 
alterations in the distribution of NCR1 splice variants within 
nasal mucosa following respiratory viral infections, as well as 
the ability of cytokine stimulation to modulate the NKp46 splice 
variant expression profile, which may be representative of condi-
tions in the infected respiratory tract. In addition, we also provide 
evidence for functional differences between the NCR1 splice 
variants, since the NKp46 domain 1-negative isoform proved to 
be functionally more active.
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